Viewing StudyNCT06452329



Ignite Creation Date: 2024-06-16 @ 11:52 AM
Last Modification Date: 2025-12-16 @ 9:59 PM
Study NCT ID: NCT06452329
Status: None
Last Update Posted: 2025-12-04 00:00:00
First Post: 2024-06-05 00:00:00

Brief Title: A Study to Evaluate Nivolumab in Patients With Unresectable Advanced/Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
Sponsor:
Organization: Bristol-Myers Squibb

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: False
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 260
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
107878
Who Masked List: